Online pharmacy 1mg raises $70 mn in funding round led by Corisol, Redwood

This round of funding puts the company's valuation at around $200 million, according to market sources

rupee
T E Narasimhan Chennai
1 min read Last Updated : Jun 28 2019 | 11:50 AM IST
1mg, an integrated healthcare platform, has closed a $70 million fundraise with participation from World Bank investment arm IFC. The financing round was led by Corisol Holdings, a European family office and largest shareholder in Zur Rose/ Doc Morris which is Europe’s largest e-pharmacy. This round of funding puts the company's valuation at around $200 million, according to market sources.

A consortium of venture capital funds from South Korea, led by Redwood Global – Korea Omega Healthcare fund, existing investors Sequoia Capital, Maverick Ventures, HBM Healthcare investments, Omidyar Network & Kae Capital also participated in the round.

Prashant Tandon, CEO of 1mg, said that the company has raised $103.5 million till now.

Tandon said with this infusion the company will increase investments in marketing, will develop a healthcare skill team of over 2,000 pharmacists and phlebotomists over the next phase. The company will also be setting up a dedicated supply chain for pharmacy as well as diagnostics and scale up its presence to provide same day delivery capabilities in over 100 cities and small towns and will set up a full initiative for the next generation data science and AI work. 


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :e-pharmacies

Next Story